|
1
|
Longley DB, Harkin DP and Johnston PG:
5-fluorouracil: Mechanisms of action and clinical strategies. Nat
Rev Cancer. 3:330–338. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Houghton JA, Tillman DM and Harwood FG:
Ratio of
2′-deoxyadenosine-5′-triphosphate/thymidine-5′-triphosphate
influences the commitment of human colon carcinoma cells to
thymineless death. Clin Cancer Res. 1:723–730. 1995.PubMed/NCBI
|
|
3
|
Sampath D, Rao VA and Plunkett W:
Mechanisms of apoptosis induction by nucleoside analogs. Oncogene.
22:9063–9074. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wilkinson DS and Pitot HC: Inhibition of
ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by
5-fluorouracil and 5-fluorouridine. J Biol Chem. 248:63–68.
1973.PubMed/NCBI
|
|
5
|
Kanamaru R, Kakuta H, Sato T, Ishioka C
and Wakui A: The inhibitory effects of 5-fluorouracil on the
metabolism of preribosomal and ribosomal RNA in L-1210 cells in
vitro. Cancer Chemother Pharmacol. 17:43–46. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ghoshal K and Jacob ST: Specific
inhibition of pre-ribosomal RNA processing in extracts from the
lymphosarcoma cells treated with 5-fluorouracil. Cancer Res.
54:632–636. 1994.PubMed/NCBI
|
|
7
|
Bhat KP, Itahana K, Jin A and Zhang Y:
Essential role of ribosomal protein L11 in mediating growth
inhibition-induced p53 activation. EMBO J. 23:2402–2412. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dai MS, Zeng SX, Jin Y, Sun XX, David L
and Lu H: Ribosomal protein L23 activates p53 by inhibiting MDM2
function in response to ribosomal perturbation but not to
translation inhibition. Mol Cell Biol. 24:7654–7668. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai MS and Lu H: Inhibition of
MDM2-mediated p53 ubiquitination and degradation by ribosomal
protein L5. J Biol Chem. 279:44475–44482. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai MS, Shi D, Jin Y, Sun XX, Zhang Y,
Grossman SR and Lu H: Regulation of the MDM2-p53 pathway by
ribosomal protein L11 involves a post-ubiquitination mechanism. J
Biol Chem. 281:24304–24313. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon
M and Vousden KH: Regulation of HDM2 activity by the ribosomal
protein L11. Cancer Cell. 3:577–587. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jin A, Itahana K, O'Keefe K and Zhang Y:
Inhibition of HDM2 and activation of p53 by ribosomal protein L23.
Mol Cell Biol. 24:7669–7680. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Wolf GW, Bhat K, Jin A, Allio T,
Burkhart WA and Xiong Y: Ribosomal protein L11 negatively regulates
oncoprotein MDM2 and mediates a p53-dependent ribosomal-stress
checkpoint pathway. Mol Cell Biol. 23:8902–8912. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sun XX, Dai MS and Lu H: 5-fluorouracil
activation of p53 involves an MDM2-ribosomal protein interaction. J
Biol Chem. 282:8052–8059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Levine AJ and Oren M: The first 30 years
of p53: Growing ever more complex. Nat Rev Cancer. 9:749–758. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Nabeya Y, Loganzo F Jr, Maslak P, Lai L,
de Oliveira AR, Schwartz GK, Blundell ML, Altorki NK, Kelsen DP and
Albino AP: The mutational status of p53 protein in gastric and
esophageal adenocarcinoma cell lines predicts sensitivity to
chemotherapeutic agents. Int J Cancer. 64:37–46. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pickard M, Dive C and Kinsella AR:
Differences in resistance to 5-fluorouracil as a function of cell
cycle delay and not apoptosis. Br J Cancer. 72:1389–1396. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Osaki M, Tatebe S, Goto A, Hayashi H,
Oshimura M and Ito H: 5-Fluorouracil (5-FU) induced apoptosis in
gastric cancer cell lines: Role of the p53 gene. Apoptosis.
2:221–226. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wright NA, Poulsom R, Stamp G, Van Noorden
S, Sarraf C, Elia G, Ahnen D, Jeffery R, Longcroft J, Pike C, et
al: Trefoil peptide gene expression in gastrointestinal epithelial
cells in inflammatory bowel disease. Gastroenterology. 104:12–20.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong CF, Lin SY, Chou YT and Wu CW:
MicroRNA-7 compromises p53 Protein-dependent apoptosis by
controlling the expression of the chromatin remodeling factor
SMARCD1. J Biol Chem. 291:1877–1889. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang Y, Nakagawa H, Tetreault MP, Billig
J, Victor N, Goyal A, Sepulveda AR and Katz JP: Loss of
transcription factor KLF5 in the context of p53 ablation drives
invasive progression of human squamous cell cancer. Cancer Res.
71:6475–6484. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Petak I, Tillman DM and Houghton JA: p53
dependence of Fas induction and acute apoptosis in response to
5-fluorouracil-leucovorin in human colon carcinoma cell lines. Clin
Cancer Res. 6:4432–4441. 2000.PubMed/NCBI
|
|
24
|
Adamsen BL, Kravik KL and De Angelis PM:
DNA damage signaling in response to 5-fluorouracil in three
colorectal cancer cell lines with different mismatch repair and
TP53 status. Int J Oncol. 39:673–682. 2011.PubMed/NCBI
|
|
25
|
Dai MS, Arnold H, Sun XX, Sears R and Lu
H: Inhibition of c-Myc activity by ribosomal protein L11. EMBO J.
26:3332–3345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boon K, Caron HN, Van Asperen R, Valentijn
L, Hermus MC, Van Sluis P, Roobeek I, Weis I, Voûte PA, Schwab M,
et al: N-myc enhances the expression of a large set of genes
functioning in ribosome biogenesis and protein synthesis. EMBO J.
20:1383–1393. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang C, Li X, Zhang J, Ge Z, Chen H and Hu
J: EZH2 contributes to 5-FU resistance in gastric cancer by
epigenetically suppressing FBXO32 expression. Onco Targets Ther.
11:7853–7864. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu X, Xiong X and Sun Y: The role of
ribosomal proteins in the regulation of cell proliferation,
tumorigenesis, and genomic integrity. Sci China Life Sci.
59:656–672. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ajani JA: Evolving chemotherapy for
advanced gastric cancer. Oncologist. 10:49–58. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhe W, Feng ZJ and Fang FG: Effect of
rhizoma curcumate zedoariae and herbra trifolii repentis on
apoptosis of human lung cancer cell line A549. J Capital Univ Med
Sci. 22:304–305. 2001.
|
|
31
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
